Grade My Investments
HomeFree Stock Grades › ABBV

AbbVie Inc. (ABBV) Stock Grade

ABBV · Healthcare

A-
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$406.8B
P/E Ratio
96.3
Revenue Growth (YoY)
+8.6%
Net Margin
6.9%
Return on Equity
15.4%
Dividend Yield
2.9%

About AbbVie Inc.'s fundamentals

AbbVie is a large-cap pharmaceutical manufacturer with $406.8 billion in market capitalization and solid revenue growth of 8.6% year-over-year. However, the company's net margin of 6.9% is relatively modest for the pharmaceutical sector, and its P/E ratio of 96.3 reflects a premium valuation relative to earnings. The company generates a 15.4% return on equity while offering a 2.9% dividend yield, indicating it retains a portion of profits for reinvestment while returning cash to shareholders.

Track ABBV free — no credit card required. Live grade + monthly AI report →